(Q40612614)

22 September 2017

1 reference

title

Comparative studies of cefprozil in the management of skin and soft-tissue infections (English)

1 reference

22 September 2017

T Nolen

1

1 reference

22 September 2017

publication date

1 October 1994

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

10

1 reference

22 September 2017

page(s)

866-871

1 reference

Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.

22 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02111354

In vitro activity of BMY-28100 against common isolates from pediatric infections

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02111354

Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02111354

In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100

21 January 2018

1 reference

12 December 2020

Comparative in vitro activity of the new oral cephalosporin BMY-28100.

1 reference

12 December 2020

Comparative antibacterial activity of the new oral cephalosporin BMY-28100

1 reference

12 December 2020

Skin-isolated, community-acquired Staphylococcus aureus: in vitro resistance to methicillin and erythromycin.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02111354

1 reference

Dimensions Publication ID

22 September 2017

1043753790

0 references

1 reference